Tristan T Sands1, Hyunmi Choi2. 1. Division of Child Neurology, Columbia University Medical Center, 180 Fort Washington Avenue, New York, NY, 10032, USA. tristan.sands@columbia.edu. 2. Division of Child Neurology, Columbia University Medical Center, 180 Fort Washington Avenue, New York, NY, 10032, USA.
Abstract
PURPOSE OF REVIEW: This article summarizes the emerging landscape of pediatric epilepsy, highlighting genetic contributions, and reviews approaches to genetic evaluation for pediatric epilepsy in this context. RECENT FINDINGS: Advances in understanding the genetic basis for epilepsy over the last several years have been due in large part to the identification of de novo genetic variation underlying sporadic severe epilepsy in children; the genetic underpinnings of the more common epilepsies remain largely unknown. Next-generation sequencing approaches have been added to the repertoire of clinical tests for the evaluation of pediatric epilepsy, improving our ability to make positive diagnoses. Yields of over 50% are now being reported in selected groups of patients. Genetic variation contributing to the risk for pediatric epilepsy spans continua of scale and influence. The highest yield of genetic testing is currently in children with sporadic severe epilepsy caused by de novo variation. The approach to genetic evaluation and interpretation of results requires an understanding of (1) the epilepsy phenotype and (2) the particular advantages and limitations of the different genetic tests available. Our understanding of genetic variation will continue to improve over time and "negative" results are best conceptualized as "unresolved" or "negative for now."
PURPOSE OF REVIEW: This article summarizes the emerging landscape of pediatric epilepsy, highlighting genetic contributions, and reviews approaches to genetic evaluation for pediatric epilepsy in this context. RECENT FINDINGS: Advances in understanding the genetic basis for epilepsy over the last several years have been due in large part to the identification of de novo genetic variation underlying sporadic severe epilepsy in children; the genetic underpinnings of the more common epilepsies remain largely unknown. Next-generation sequencing approaches have been added to the repertoire of clinical tests for the evaluation of pediatric epilepsy, improving our ability to make positive diagnoses. Yields of over 50% are now being reported in selected groups of patients. Genetic variation contributing to the risk for pediatric epilepsy spans continua of scale and influence. The highest yield of genetic testing is currently in children with sporadic severe epilepsy caused by de novo variation. The approach to genetic evaluation and interpretation of results requires an understanding of (1) the epilepsy phenotype and (2) the particular advantages and limitations of the different genetic tests available. Our understanding of genetic variation will continue to improve over time and "negative" results are best conceptualized as "unresolved" or "negative for now."
Authors: R H Wallace; I E Scheffer; S Barnett; M Richards; L Dibbens; R R Desai; T Lerman-Sagie; D Lev; A Mazarib; N Brand; B Ben-Zeev; I Goikhman; R Singh; G Kremmidiotis; A Gardner; G R Sutherland; A L George; J C Mulley; S F Berkovic Journal: Am J Hum Genet Date: 2001-03-13 Impact factor: 11.025
Authors: Leanne M Dibbens; Saul Mullen; Ingo Helbig; Heather C Mefford; Marta A Bayly; Susannah Bellows; Costin Leu; Holger Trucks; Tanja Obermeier; Michael Wittig; Andre Franke; Hande Caglayan; Zuhal Yapici; Thomas Sander; Evan E Eichler; Ingrid E Scheffer; John C Mulley; Samuel F Berkovic Journal: Hum Mol Genet Date: 2009-07-10 Impact factor: 6.150
Authors: Tristan T Sands; Martina Balestri; Giulia Bellini; Sarah B Mulkey; Olivier Danhaive; Eliza Hayes Bakken; Maurizio Taglialatela; Michael S Oldham; Federico Vigevano; Gregory L Holmes; Maria Roberta Cilio Journal: Epilepsia Date: 2016-11-26 Impact factor: 5.864
Authors: Heather C Mefford; Simone C Yendle; Cynthia Hsu; Joseph Cook; Eileen Geraghty; Jacinta M McMahon; Orvar Eeg-Olofsson; Lynette G Sadleir; Deepak Gill; Bruria Ben-Zeev; Tally Lerman-Sagie; Mark Mackay; Jeremy L Freeman; Eva Andermann; James T Pelakanos; Ian Andrews; Geoffrey Wallace; Evan E Eichler; Samuel F Berkovic; Ingrid E Scheffer Journal: Ann Neurol Date: 2011-12 Impact factor: 10.422
Authors: R Singh; E Andermann; W P Whitehouse; A S Harvey; D L Keene; M H Seni; K M Crossland; F Andermann; S F Berkovic; I E Scheffer Journal: Epilepsia Date: 2001-07 Impact factor: 5.864
Authors: Anne T Berg; Samuel F Berkovic; Martin J Brodie; Jeffrey Buchhalter; J Helen Cross; Walter van Emde Boas; Jerome Engel; Jacqueline French; Tracy A Glauser; Gary W Mathern; Solomon L Moshé; Douglas Nordli; Perrine Plouin; Ingrid E Scheffer Journal: Epilepsia Date: 2010-02-26 Impact factor: 5.864
Authors: Heather C Mefford; Hiltrud Muhle; Philipp Ostertag; Sarah von Spiczak; Karen Buysse; Carl Baker; Andre Franke; Alain Malafosse; Pierre Genton; Pierre Thomas; Christina A Gurnett; Stefan Schreiber; Alexander G Bassuk; Michel Guipponi; Ulrich Stephani; Ingo Helbig; Evan E Eichler Journal: PLoS Genet Date: 2010-05-20 Impact factor: 5.917
Authors: Maureen S Mulhern; Constance Stumpel; Nicholas Stong; Han G Brunner; Louise Bier; Natalie Lippa; James Riviello; Rob P W Rouhl; Marlies Kempers; Rolph Pfundt; Alexander P A Stegmann; Mary K Kukolich; Aida Telegrafi; Anna Lehman; Elena Lopez-Rangel; Nada Houcinat; Magalie Barth; Nicolette den Hollander; Mariette J V Hoffer; Sarah Weckhuysen; Jolien Roovers; Tania Djemie; Diana Barca; Berten Ceulemans; Dana Craiu; Johannes R Lemke; Christian Korff; Heather C Mefford; Candace T Meyers; Zsuzsanna Siegler; Susan M Hiatt; Gregory M Cooper; E Martina Bebin; Lot Snijders Blok; Hermine E Veenstra-Knol; Evan H Baugh; Eva H Brilstra; Catharina M L Volker-Touw; Ellen van Binsbergen; Anya Revah-Politi; Elaine Pereira; Danielle McBrian; Mathilde Pacault; Bertrand Isidor; Cedric Le Caignec; Brigitte Gilbert-Dussardier; Frederic Bilan; Erin L Heinzen; David B Goldstein; Servi J C Stevens; Tristan T Sands Journal: Ann Neurol Date: 2018-10-25 Impact factor: 10.422
Authors: Paolo Ambrosino; Elena Freri; Barbara Castellotti; Maria Virginia Soldovieri; Ilaria Mosca; Laura Manocchio; Cinzia Gellera; Laura Canafoglia; Silvana Franceschetti; Barbara Salis; Nunzio Iraci; Francesco Miceli; Francesca Ragona; Tiziana Granata; Jacopo C DiFrancesco; Maurizio Taglialatela Journal: Mol Neurobiol Date: 2018-01-30 Impact factor: 5.590
Authors: Jorune Balciuniene; Elizabeth T DeChene; Gozde Akgumus; Edward J Romasko; Kajia Cao; Holly A Dubbs; Surabhi Mulchandani; Nancy B Spinner; Laura K Conlin; Eric D Marsh; Ethan Goldberg; Ingo Helbig; Mahdi Sarmady; Ahmad Abou Tayoun Journal: JAMA Netw Open Date: 2019-04-05